investiment.io
Exicure, Inc.
$12.75
6.93 (119.14%)
Exicure, Inc.
$12.75
6.93 (119.14%)
XCUR Price Chart
| Basic | |
|---|---|
| Market Cap | $4.59M |
| Price | $11.19 |
| 52 Week Range | 1.44-6.0 |
| Beta | 1.28 |
| Margins | |
| Gross Profit Margin | 40.85% |
| Operating Profit Margin | -351.28% |
| Net Profit Margin | -394.39% |
| Valuation (TTM) | |
| P/E Ratio | -24.55 |
| Price to Sales Ratio | 24.31 |
| Price to Book Ratio | 63.67 |
| PEG Ratio | -0.42 |
Industry
Biotechnology
Sector
Healthcare
Full-Time Employees
5
Website
IPO Date
2018-05-22T00:00:00.000Z
Description
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Phone
847 673 1700
Address
2430 North Halsted Street, Chicago, IL, 60614, US
CIK
0001698530